全文获取类型
收费全文 | 3873篇 |
免费 | 198篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 59篇 |
妇产科学 | 25篇 |
基础医学 | 432篇 |
口腔科学 | 83篇 |
临床医学 | 329篇 |
内科学 | 1266篇 |
皮肤病学 | 60篇 |
神经病学 | 352篇 |
特种医学 | 86篇 |
外科学 | 702篇 |
综合类 | 10篇 |
预防医学 | 122篇 |
眼科学 | 48篇 |
药学 | 215篇 |
中国医学 | 5篇 |
肿瘤学 | 250篇 |
出版年
2023年 | 26篇 |
2022年 | 75篇 |
2021年 | 115篇 |
2020年 | 58篇 |
2019年 | 94篇 |
2018年 | 101篇 |
2017年 | 83篇 |
2016年 | 89篇 |
2015年 | 86篇 |
2014年 | 128篇 |
2013年 | 176篇 |
2012年 | 248篇 |
2011年 | 242篇 |
2010年 | 143篇 |
2009年 | 109篇 |
2008年 | 229篇 |
2007年 | 211篇 |
2006年 | 195篇 |
2005年 | 200篇 |
2004年 | 180篇 |
2003年 | 204篇 |
2002年 | 188篇 |
2001年 | 85篇 |
2000年 | 77篇 |
1999年 | 70篇 |
1998年 | 34篇 |
1997年 | 35篇 |
1996年 | 23篇 |
1995年 | 15篇 |
1994年 | 19篇 |
1992年 | 26篇 |
1991年 | 31篇 |
1990年 | 43篇 |
1989年 | 35篇 |
1988年 | 29篇 |
1987年 | 32篇 |
1986年 | 24篇 |
1985年 | 18篇 |
1984年 | 16篇 |
1979年 | 16篇 |
1976年 | 16篇 |
1975年 | 30篇 |
1973年 | 17篇 |
1972年 | 20篇 |
1971年 | 20篇 |
1970年 | 31篇 |
1969年 | 16篇 |
1968年 | 18篇 |
1967年 | 25篇 |
1966年 | 19篇 |
排序方式: 共有4098条查询结果,搜索用时 420 毫秒
101.
Yasuhiro Yoshiga Akihiko Shimizu Toshihiko Yamagata Masahiro Esato Takeshi Ueyama Masato Ohmura Kazuo Itagaki Masayasu Kimura Hiroyuki Kakugawa Masahiro Doi Masunori Matsuzaki 《Circulation journal》2003,67(5):437-442
The aims of this study were to evaluate the changes in the electrophysiological characteristics of the right atrium after the administration of flecainide and to clarify whether flecainide has a selective effect on human atrial tissue. Electrophysiological measurements were made in 38 patients, before and after intravenous administration of flecainide (2 mg/kg per 10 min). The effective refractory period of the right atrium (ERP-A), maximum conduction delay (Max.CD), repetitive atrial firing zone (RAFZ), fragmented atrial activity zone (FAAZ), and conduction delay zone (CDZ) were studied in the patients who were divided into 2 groups based on whether repetitive atrial firing (RAF) was induced in the baseline study. Flecainide significantly prolonged the ERP-A (202+/-22 to 238+/-33 ms, p<0.001) and shortened Max.CD (77+/-17 to 63+/-32 ms, p<0.05) in the patients with RAF, but not in those without RAF in the baseline study. After flecainide administration, there were significant reductions in the RAFZ (43+/-22 to 13+/-19 ms, p<0.0001), FAAZ (51+/-22 to 28+/-26 ms, p<0.001) and CDZ (70+/-21 to 48+/-30 ms, p<0.01) in the patients with RAF. However, atrial fibrillation (AF) was induced by stimulation after flecainide in 2 patients without RAF in the baseline study. There was a significant negative correlation between the ERP-A in the baseline study and the change in the ERP-A upon flecainide administration (r=0.45, p<0.01). Flecainide may preferentially activate the substrate for AF and RAF, but that action is mainly based on the electrophysiological characteristics found in the baseline study. 相似文献
102.
The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia 总被引:6,自引:0,他引:6
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Junge CE Sugawara T Mannaioni G Alagarsamy S Conn PJ Brat DJ Chan PH Traynelis SF 《Proceedings of the National Academy of Sciences of the United States of America》2003,100(22):13019-13024
The serine proteases tissue plasminogen activator, plasmin, and thrombin and their receptors have previously been suggested to contribute to neuronal damage in certain pathological situations. Here we demonstrate that mice lacking protease-activated receptor 1 (PAR1) have a 3.1-fold reduction in infarct volume after transient focal cerebral ischemia. Intracerebroventricular injection of PAR1 antagonist BMS-200261 reduced infarct volume 2.7-fold. There are no detectable differences between PAR1-/- and WT mice in cerebrovascular anatomy, capillary density, or capillary diameter, demonstrating that the neuroprotective phenotype is not likely related to congenital abnormalities in vascular development. We also show that the exogenously applied serine proteases thrombin, plasmin, and tissue plasminogen activator can activate PAR1 signaling in brain tissue. These data together suggest that if blood-derived serine proteases that enter brain tissue in ischemic situations can activate PAR1, this sequence of events may contribute to the harmful effects observed. Furthermore, PAR1 immunoreactivity is present in human brain, suggesting that inhibition of PAR1 may provide a novel potential therapeutic strategy for decreasing neuronal damage associated with ischemia and blood-brain barrier breakdown. 相似文献
103.
Imamura H Takayama T Sugawara Y Kokudo N Aoki T Kaneko J Matsuyama Y Sano K Maema A Makuuchi M 《Lancet》2002,360(9350):2049-2050
The safety of the donor is paramount in living donor liver transplantation. The most important risk to the donor during hepatectomy is bleeding, and the inflow occlusion technique (Pringle's manoeuvre) has been reported to decrease bleeding without inducing liver injury in liver surgery. However, most transplant centres are doing donor hepatectomies without this technique for fear that it would result in ischaemic injury to the graft. We have done 46 living donor hepatectomies with Pringle's manoeuvre without any negative outcome on the quality of the graft. Surgeons should not hesitate to apply this technique in living donor hepatectomy. 相似文献
104.
105.
106.
107.
Masatsugu Ohara Goki Suda Megumi Kimura Osamu Maehara Tomoe Shimazaki Taku Shigesawa Kazuharu Suzuki Akihisa Nakamura Naoki Kawagishi Masato Nakai Takuya Sho Mitsuteru Natsuizaka Kenichi Morikawa Koji Ogawa Tomoe Kobayashi Minoru Uebayashi Ryo Takagi Isao Yokota Tsuyoshi Shimamura Naoya Sakamoto 《Hepatology research》2020,50(6):715-725
108.
109.
Go Kuwata Terumi Kamisawa Koichi Koizumi Taku Tabata Seiichi Hara Sawako Kuruma Takashi Fujiwara Kazuro Chiba Hideto Egashira Junko Fujiwara Takeo Arakawa Kumiko Momma Shinichiro Horiguchi 《Gut and liver》2014,8(1):29-34